Clinical trials: Post-transplant Diabetes Mellitus
Post-transplant Diabetes Mellitus, Kidney Transplant; Complications
Define Predictors for Posttransplant Diabetes Mellitus Study
The primary aim of this prospective, multicentre study is to develop an accurate and convenient tool to predict the risk of PTDM at 3 months post-transplant, based on information on the day of transplantation (day 0).
- Trial name
- DECODE (NCT06440330)
- Testing
- continuous glucose monitoring
- Where
- Belgium
- Volunteers
- 330 people, healthy volunteers welcome
- Sponsor
- University Hospital, Antwerp
Post-transplant Diabetes Mellitus
GLP-1 Effects on Insulin and Glucagon in PTDM
Post-transplantation diabetes mellitus (PTDM) develops in 10-15 % of all renal transplant recipients within 10 weeks after transplantation, and has been associated with increased risk of cardiovascular disease and impaired…
- Trial name
- NCT02591849
- Testing
- Glucagon-like peptide-1 (GLP-1), Isotonic saline, Hyperglycemic clamp
- Where
- Norway
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Oslo University Hospital